Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Census population 383,997. Louisiana Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Orleans clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Orleans storefront.
Wharton's Jelly Allograft Products in New Orleans, LA for clinics & physicians. Wharton's jelly allografts… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 25.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. whartons jelly allograft inventory is national; utilization is JH-local.
National Wharton's Jelly Allograft Products notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For New Orleans we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure.
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 8.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 15.1% of adults — 3.1 points above the U.S. 12% figure. Obesity is 34%; arthritis is 25.3%. That is place-level BRFSS modeling, not a clinic census and not a New Orleans trial.
Louisiana is JH. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Ask for the IFU, the lot-traceability packet, and the Novitas Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a New Orleans fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in New Orleans, LA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Orleans is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Orleans — 3.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Louisiana Part B wound biologics follow this contractor (siblings: AR, CO, MS, NM, OK, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Orleans. Useful for joint-program math; still needs a diagnosis and privileging.
No New Orleans storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.